For those getting IV therapy, keeping a balanced diet is vital
After 52 weeks, participants who took 36 milligrams of orforglipron saw a key blood sugar marker reduce by nearly 2 percent, while those who received 14 milligrams of oral semaglutide saw levels drop by nearly 1.5 percent
Actual values vary by plan and drug indication
For the 96.4% of adults without deficiency, however, injections offer no performance advantage despite marketing claims suggesting otherwise
doi:10.2337/diabetes.54.8.2375 39
Three groups were identified: participants with current MDD (that is, participants meeting DSM-IV criteria for MDD within the past 6 months), with remitted (i.e., lifetime but not current) MDD, and healthy controls (without any lifetime depressive/anxiety disorder)